Document Detail


Prenatal tobacco exposure, biomarkers for tobacco in meconium, and neonatal growth outcomes.
MedLine Citation:
PMID:  23211926     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To assess relationships between marker concentrations of tobacco in meconium and weekly self-reported maternal cigarette consumption, and prediction of neonatal growth outcomes.
STUDY DESIGN: Pregnant mothers (n = 119) from a longitudinal maternal smoking and infant neurobehavioral study (Behavior and Mood in Babies and Mothers [BAM BAM]) provided daily tobacco smoking histories. Nicotine, cotinine, and trans-3'-hydroxycotinine concentrations were quantified in 111 neonatal meconium specimens by liquid chromatography-tandem mass spectrometry.
RESULTS: Median self-reported third trimester smoking was 5.9 cigarettes per day among smokers. Meconium samples from infants born to non-smokers (n = 42) were negative for tobacco markers, while specimens from self-reported smokers (n = 41) were positive for (median, range) nicotine (50.1 ng/g, 3.9-294), cotinine (73.9 ng/g, 6.4-329), and trans-3'-hydroxycotinine (124.5 ng/g, 10.2-478). Quitters (n = 28) self-reported stopping smoking at gestational weeks 2-39. Four meconium specimens from quitters were positive for tobacco biomarkers. Reduced birth weight, length, and head circumference significantly correlated with presence of meconium markers but not with individual or total marker concentrations. Among quitters and smokers, reduced infant birth weight, head circumference, and gestational age correlated with total and average daily cigarette consumption in the second and third trimesters.
CONCLUSION: Smoking cessation or reduction during pregnancy improved neonatal outcomes. The window of detection for tobacco in meconium appears to be the third trimester; however, low exposure in this trimester failed to be detected. These results will aid physicians in educating women who are pregnant or thinking about becoming pregnant on the negative consequences of smoking during pregnancy. In addition, infants at risk can be identified at birth to assist early intervention efforts.
Authors:
Sarah K Himes; Laura R Stroud; Karl B Scheidweiler; Raymond S Niaura; Marilyn A Huestis
Related Documents :
322636 - The sudden infant death syndrome: a review of recent advances.
3724796 - Death-scene investigation in sudden infant death.
9343276 - The decline in the incidence of sids in scandinavia and its relation to risk-interventi...
17597646 - Sudden infant death syndrome: rare mutation in the serotonin system fev gene.
18400716 - Home fortification of complementary foods with micronutrient supplements is well accept...
17294436 - Growth and developmental outcomes of three high-risk infant rhesus macaques (macaca mul...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural     Date:  2012-12-01
Journal Detail:
Title:  The Journal of pediatrics     Volume:  162     ISSN:  1097-6833     ISO Abbreviation:  J. Pediatr.     Publication Date:  2013 May 
Date Detail:
Created Date:  2013-04-26     Completed Date:  2013-07-12     Revised Date:  2013-08-19    
Medline Journal Info:
Nlm Unique ID:  0375410     Medline TA:  J Pediatr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  970-5     Citation Subset:  AIM; IM    
Copyright Information:
Published by Mosby, Inc.
Affiliation:
Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Biological Markers / analysis
Chromatography, Liquid
Cotinine / analogs & derivatives*,  analysis*
Female
Humans
Infant, Newborn
Longitudinal Studies
Maternal Exposure*
Maternal-Fetal Exchange*
Meconium / chemistry*
Nicotine / analysis
Pregnancy
Prenatal Exposure Delayed Effects / diagnosis,  etiology*
Smoking / adverse effects*
Tandem Mass Spectrometry
Tobacco / adverse effects*
Young Adult
Grant Support
ID/Acronym/Agency:
R01 DA019558/DA/NIDA NIH HHS
Chemical
Reg. No./Substance:
0/Biological Markers; 27323-64-4/hydroxycotinine; 486-56-6/Cotinine; 54-11-5/Nicotine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Mechanisms of Nuclear Suppression of Host Immunity by Effectors from the Arabidopsis Downy Mildew Pa...
Next Document:  Adiposity in adolescent offspring born prematurely to mothers with preeclampsia.